ICON plc operates as a clinical research organization, which engages in the provision of outsourced development services to the pharmaceutical, biotechnology, and medical device industries.

Gainers Kanzhun Limited (NASDAQ: BZ) shares climbed 95.8% to close at $37.20 on Friday after the company priced its IPO at $19 per share.

Key Insights ICON's estimated fair value is US$345 based on 2 Stage Free Cash Flow to Equity ICON's US$186 share price... Icon PLC (ICLR) doesn't possess the right combination of the two key ...

Real time quote data is not available at this time. *Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green ...

Lekha Gupta Clinical Research Firm ICON Faces Headwinds From Top Customers And Biotech Recovery Uncertainty ICON forecasts 2025 revenue at $8.05 billion–$8.65 billion and adjusted EPS of $13.00 ...

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally.